Literature DB >> 2981126

Hepatitis A antibodies: prevalence and persistence in a group of Mexican children.

J Ruiz-Gomez, M E Bustamante-Calvillo.   

Abstract

The prevalence of antibodies against hepatitis A virus (anti-HAV) was evaluated in sera from 275 asymptomatic infants and children under the age of five years and in 46 maternal-cord serum pairs, followed by sera obtained thereafter each month from the first to the fifth month of life in 29, 17, 9, 9 and 7 infants (a total of 163 serum samples). Anti-HAV was found in all cord blood sera, but its prevalence declined progressively to 0% among 19 infants aged eight months. Four (25%) of 16 children aged one year had positive anti-HAV and the antibody prevalence was 89% in children five years old. Recent hepatitis A infection shown by circulating anti-HAV immunoglobulin M was detected in five infants under the age of two months and with frequencies ranging from 19-67% in one- and five-year-old children. It was concluded that in children living in Mexico City, hepatitis A infections occur at an earlier age and at higher rates than in children in other cities, especially those in developed countries.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981126     DOI: 10.1093/oxfordjournals.aje.a113973

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

1.  Shifts in the rates and levels of antibody to hepatitis A virus associated with hepatitis A infection in children's communities.

Authors:  S A Prikazchikov; M S Balayan
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Decline of hepatitis A antibodies during the first 7 months of life in full-term and preterm infants.

Authors:  N Linder; Y Karetnyi; Y Gidony; R Dagan; G Ohel; E Levin; E Mendelson; A Barzilai
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

3.  Determinants of anti-hepatitis A antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007-2008.

Authors:  E Velasco-Mondragon; I Lindong; F Kamangar
Journal:  Epidemiol Infect       Date:  2011-05-09       Impact factor: 2.451

Review 4.  Viral Hepatitis - The Road Traveled and the Journey Remaining.

Authors:  Ghulam Fareed Malik; Noval Zakaria; Muhammad Ibrahim Majeed; Faisal Wasim Ismail
Journal:  Hepat Med       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.